GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

XiAn International Medical Investment Co 000516.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

4.58

-0.43%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥4.07bn

FY2016FY2025

Net income

−CN¥313.1m

FY2016FY2025

Free cash flow

CN¥1.01bn

FY2016FY2025

Shareholders' equity

CN¥3.32bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥4.07bnCN¥4.82bnCN¥4.62bnCN¥2.71bnCN¥2.92bnCN¥1.61bnCN¥991.0mCN¥2.04bnCN¥4.06bnCN¥3.93bn
Research and developmentCN¥7.6mCN¥7.0mCN¥9.8mCN¥15.5mCN¥12.8mCN¥9.7mCN¥7.7mCN¥1.5mCN¥1.5mCN¥1.5m
Operating income−CN¥256.2m−CN¥196.1m−CN¥322.7m−CN¥955.6m−CN¥742.7mCN¥7.9m−CN¥342.0mCN¥3.05bnCN¥267.7mCN¥273.9m
Net income−CN¥313.1m−CN¥254.1m−CN¥368.4m−CN¥1.18bn−CN¥822.2mCN¥45.4m−CN¥403.9mCN¥2.18bnCN¥194.5mCN¥201.6m
Diluted earnings per share-0.14-0.11-0.15-0.53-0.370.02-0.210.940.100.10

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥9.71bnCN¥10.64bnCN¥11.32bnCN¥13.26bnCN¥13.32bnCN¥12.12bnCN¥10.03bnCN¥7.31bnCN¥5.83bnCN¥5.56bn
Cash and short-term investments—CN¥679.6mCN¥1.08bnCN¥1.34bnCN¥1.81bnCN¥1.55bnCN¥1.39bnCN¥1.44bnCN¥1.95bnCN¥2.67bn
Total liabilitiesCN¥6.70bnCN¥7.16bnCN¥7.51bnCN¥9.01bnCN¥7.99bnCN¥7.09bnCN¥5.03bnCN¥1.53bnCN¥2.20bnCN¥2.06bn
DebtCN¥2.17bnCN¥3.82bnCN¥3.98bnCN¥4.47bnCN¥5.10bnCN¥4.62bnCN¥3.41bnCN¥712.0mCN¥961.0mCN¥1.03bn
Shareholders' equityCN¥3.32bnCN¥3.67bnCN¥3.91bnCN¥4.25bnCN¥5.33bnCN¥5.00bnCN¥4.96bnCN¥5.73bnCN¥3.62bnCN¥3.49bn
Shares outstanding2,239m2,284m2,424m2,223m2,244m1,929m1,947m2,317m1,982m1,980m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.28bnCN¥1.01bnCN¥1.09bnCN¥461.3mCN¥456.3mCN¥41.3m−CN¥34.3m−CN¥772.1mCN¥386.4mCN¥439.3m
Capital spending−CN¥262.5m−CN¥547.7m−CN¥762.7m−CN¥1.19bn−CN¥1.66bn−CN¥1.34bn−CN¥3.61bn−CN¥1.70bn−CN¥894.1m−CN¥227.2m
Free cash flowCN¥1.01bnCN¥461.4mCN¥324.7m−CN¥726.5m−CN¥1.20bn−CN¥1.30bn−CN¥3.65bn−CN¥2.47bn−CN¥507.8mCN¥212.0m
Dividends paid−CN¥149.2m−CN¥183.7m−CN¥217.4m−CN¥245.4m−CN¥232.3m−CN¥196.4m−CN¥167.9m−CN¥23.3m−CN¥102.9m−CN¥86.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.06bnCN¥969.4mCN¥1.08bnCN¥961.1mCN¥1.04bnCN¥997.1mCN¥1.21bnCN¥1.19bn
Operating incomeCN¥2.2m−CN¥43.1m−CN¥30.7m−CN¥107.9m−CN¥82.8m−CN¥104.2m−CN¥51.5m−CN¥48.1m
Net income−CN¥17.0m−CN¥48.3m−CN¥19.4m−CN¥128.7m−CN¥58.6m−CN¥106.4m−CN¥42.0m−CN¥38.5m
Diluted earnings per share-0.01-0.02-0.01-0.06-0.03-0.05-0.02-0.02
Cash from operations———CN¥328.0mCN¥348.0mCN¥244.0m—CN¥98.0m
Capital spending−CN¥56.0m−CN¥43.0m−CN¥27.0m−CN¥27.0m−CN¥57.0m−CN¥149.0m−CN¥89.0m−CN¥92.0m
Free cash flow———CN¥301.0mCN¥291.0mCN¥95.0m—CN¥6.0m
Total assetsCN¥9.19bnCN¥9.50bnCN¥9.71bnCN¥9.79bnCN¥10.01bnCN¥10.32bnCN¥10.64bnCN¥10.55bn
Cash and short-term investments———CN¥344.9mCN¥413.1mCN¥487.4mCN¥679.6mCN¥500.0m
DebtCN¥1.94bnCN¥2.12bnCN¥2.17bnCN¥1.95bnCN¥3.45bnCN¥3.74bnCN¥3.82bnCN¥3.75bn
Shareholders' equityCN¥3.25bnCN¥3.27bnCN¥3.32bnCN¥3.34bnCN¥3.47bnCN¥3.57bnCN¥3.67bnCN¥3.65bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.5%20.5%0.4%
Operating income-35.5%——
Net income-35.7%——

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-5.1%-10.7%-11.9%3.1%
Net margin-6.4%-13.0%-13.9%-1.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-30.7-47.5-53.4-23.1-30.1—-23.45.349.877.6
Price to sales2.42.54.310.08.515.19.55.62.44.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 28 Jun 2019.

FY2019FY2017FY2016FY2014FY2013FY2012FY2010FY2009
Paid in the year0.0870.030.020.020.020.020.0130.02
  • 5-for-2 split · 19 May 2016
  • 2-for-1 split · 5 Jun 2009
  • 1-to-1 reverse split · 31 Mar 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.